AG
TYRA icon

Algert Global’s Tyra Biosciences TYRA Stock Holding History

Algert Global’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.64M Buy
239,120
+51,110
+27% +$1.69M 0.09% 370
2026
Q1 		$7.2M Buy
188,010
+141,140
+301% +$4.57M 0.11% 327
2025
Q4 		$1.23M Buy
+46,870
New +$861K 0.02% 808

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Algert Global's TYRA Position: Q2 2026 in Review

Algert Global increased its Tyra Biosciences (TYRA) stake by 27% in Q2 2026, buying an estimated $1.69M and bringing the position to 239,120 shares worth $7.64M. The position accounts for 0.09% of the portfolio, ranked #370.

Algert Global first reported a position in TYRA in Q4 2025 and has held it in 3 quarters since. 168 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • Algert Global held 239,120 shares of Tyra Biosciences worth $7.64M as of Q2 2026.
  • Algert Global bought 51,110 Tyra Biosciences shares in Q2 2026, an estimated $1.69M.
  • Tyra Biosciences made up 0.09% of Algert Global's portfolio in Q2 2026, its #370 holding.
  • Algert Global first reported a position in Tyra Biosciences in Q4 2025 and has held it in 3 quarters since.
  • 168 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.